Seven research abstracts. Two panel speakers. One commitment to advancing infectious disease science and public health in Africa.
IFAIN is proud to participate in the 21st International Congress on Infectious Diseases (ICID 2026) in Madrid, Spain, bringing our research, scientific expertise and perspectives from Nigeria to a global audience.
Over the next three days, IFAIN researchers and collaborators will share seven scientific abstracts highlighting our growing portfolio of research across antimicrobial resistance (AMR), paediatric infectious diseases, clinical microbiology, molecular diagnostics, malaria epidemiology and artificial intelligence in healthcare.
Our scientific contributions include:
🔬 Antimicrobial Resistance and Molecular Epidemiology
* Phenotypic and Molecular Characterisation of Carbapenem-Resistant Invasive Bacterial Pathogens in Paediatric Bloodstream Infections in Abuja.
🧫 Clinical Microbiology and Diagnostic Innovation
* Uncovering Fastidious Pathogens: A Clinical Case Report of Haemophilus influenzae Isolation Only After Uninterrupted 48-Hour Incubation.
* Comparative Analysis of Bacterial Identification Results Using Conventional (API®️ 20E) and Automated (VITEK®️ 2 Compact) Methods in Clinical Microbiology.
* Uncovering Invasive Yeast Pathogens in Paediatric Bloodstream Infections: Insights from the Combatting Antimicrobial Resistance in Africa Using Data Science (CAMRA) Project.
🦟 Malaria Epidemiology and Community Perspectives
* Seasonal Variation in Malaria Risk Across Northern and Southern Nigeria: A Comparative Study of Market Women’s Perceptions.
🤖 Artificial Intelligence for Clinical Decision-Making
* A Gated Artificial Intelligence System for Predicting Serious Bacterial Infection Among Children in Resource-Constrained Settings: Development and Internal Validation in Northern Nigeria.
Beyond the scientific presentations, IFAIN is contributing to the global policy dialogue on vaccination and antimicrobial resistance. Our CEO Prof. Ehimario Igumbor, and Dr. Babatunde Ogunbosi will participate as panel speakers in a dedicated VacAMR scientific session, bringing perspectives on the evidence, policy and implementation priorities for leveraging vaccination to combat AMR.
We are also delighted to have Prof. Stephen Obaro, IFAIN’s Founder and Chief Scientific Officer, participating in the Congress, reinforcing our commitment to scientific leadership, mentorship and international collaboration.
For IFAIN, ICID 2026 represents more than an opportunity to disseminate research. It is a platform to demonstrate the importance of African-led scientific inquiry, strengthen international partnerships and translate evidence generated in our laboratories, hospitals and communities into solutions with global relevance.
IFAIN at ICID 2026: Advancing African Science, Strengthening Global Evidence
Event
November 2026 Madrid, Spain IFAIN